ALMS1 has been consistently associated with chronic kidney disease in population studies [44, 54] and in a monogenic disorder (Alstrom syndrome, OMIM #203,800) [33, 55], and obesity and insulin resistance in experimental models [56]. Here, ALMS1 is linked to obesity disorder.